Literature DB >> 23946447

TGFβ signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin.

Jennifer M James1, Ani Nalbandian, Yoh-suke Mukouyama.   

Abstract

Dermal lymphatic endothelial cells (LECs) emerge from the dorsolateral region of the cardinal veins within the anterior trunk to form an intricate, branched network of lymphatic vessels during embryogenesis. Multiple growth factors and receptors are required for specification and maintenance of LECs, but the mechanisms coordinating LEC movements and morphogenesis to develop three-dimensional lymphatic network architecture are not well understood. Here, we demonstrate in mice that precise LEC sprouting is a key process leading to stereotypical lymphatic network coverage throughout the developing skin, and that transforming growth factor β (TGFβ) signaling is required for LEC sprouting and proper lymphatic network patterning in vivo. We utilized a series of conditional mutants to ablate the TGFβ receptors Tgfbr1 (Alk5) and Tgfbr2 in LECs. To analyze lymphatic defects, we developed a novel, whole-mount embryonic skin imaging technique to visualize sprouting lymphangiogenesis and patterning at the lymphatic network level. Loss of TGFβ signaling in LECs leads to a severe reduction in local lymphangiogenic sprouting, resulting in a significant decrease in global lymphatic network branching complexity within the skin. Our results also demonstrate that TGFβ signaling negatively regulates LEC proliferation during lymphatic network formation. These data suggest a dual role for TGFβ signaling during lymphatic network morphogenesis in the skin, such that it enhances LEC sprouting and branching complexity while attenuating LEC proliferation.

Entities:  

Keywords:  Dermal lymphangiogenesis; LEC sprouting; TGFβ

Mesh:

Substances:

Year:  2013        PMID: 23946447      PMCID: PMC3754483          DOI: 10.1242/dev.095026

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  48 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 2.  Signaling by members of the TGF-beta family in vascular morphogenesis and disease.

Authors:  Evangelia Pardali; Marie-José Goumans; Peter ten Dijke
Journal:  Trends Cell Biol       Date:  2010-07-23       Impact factor: 20.808

3.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1.

Authors:  L D Urness; L K Sorensen; D Y Li
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

4.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Authors:  T Mäkinen; L Jussila; T Veikkola; T Karpanen; M I Kettunen; K J Pulkkanen; R Kauppinen; D G Jackson; H Kubo; S Nishikawa; S Ylä-Herttuala; K Alitalo
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

5.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Authors:  M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

6.  Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.

Authors:  J Larsson; M J Goumans; L J Sjöstrand; M A van Rooijen; D Ward; P Levéen; X Xu; P ten Dijke; C L Mummery; S Karlsson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

7.  Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable.

Authors:  Per Levéen; Jonas Larsson; Mats Ehinger; Corrado M Cilio; Martin Sundler; Lottie Jansson Sjöstrand; Rikard Holmdahl; Stefan Karlsson
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

8.  Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.

Authors:  N J Laping; E Grygielko; A Mathur; S Butter; J Bomberger; C Tweed; W Martin; J Fornwald; R Lehr; J Harling; L Gaster; J F Callahan; B A Olson
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

9.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Authors:  Gareth J Inman; Francisco J Nicolás; James F Callahan; John D Harling; Laramie M Gaster; Alastair D Reith; Nicholas J Laping; Caroline S Hill
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

10.  Abnormal lymphatic vessel development in neuropilin 2 mutant mice.

Authors:  Li Yuan; Delphine Moyon; Luc Pardanaud; Christiane Bréant; Marika J Karkkainen; Kari Alitalo; Anne Eichmann
Journal:  Development       Date:  2002-10       Impact factor: 6.868

View more
  40 in total

Review 1.  Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.

Authors:  Bruce A Corliss; Mohammad S Azimi; Jennifer M Munson; Shayn M Peirce; Walter L Murfee
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

2.  Murine Notch1 is required for lymphatic vascular morphogenesis during development.

Authors:  Anees Fatima; Austin Culver; Ford Culver; Ting Liu; William H Dietz; Benjamin R Thomson; Anna-Katerina Hadjantonakis; Susan E Quaggin; Tsutomu Kume
Journal:  Dev Dyn       Date:  2014-04-17       Impact factor: 3.780

Review 3.  A tale of two models: mouse and zebrafish as complementary models for lymphatic studies.

Authors:  Jun-Dae Kim; Suk-Won Jin
Journal:  Mol Cells       Date:  2014-05-23       Impact factor: 5.034

4.  Pkd1 regulates lymphatic vascular morphogenesis during development.

Authors:  Baptiste Coxam; Amélie Sabine; Neil I Bower; Kelly A Smith; Cathy Pichol-Thievend; Renae Skoczylas; Jonathan W Astin; Emmanuelle Frampton; Muriel Jaquet; Philip S Crosier; Robert G Parton; Natasha L Harvey; Tatiana V Petrova; Stefan Schulte-Merker; Mathias Francois; Benjamin M Hogan
Journal:  Cell Rep       Date:  2014-04-24       Impact factor: 9.423

5.  Whole-genome resequencing reveals loci with allelic transmission ratio distortion in F1 chicken population.

Authors:  Peng Ren; Feilong Deng; Shiyi Chen; Jinshan Ran; Jingjing Li; Lingqian Yin; Yan Wang; Huadong Yin; Qing Zhu; Yiping Liu
Journal:  Mol Genet Genomics       Date:  2021-01-06       Impact factor: 3.291

Review 6.  Activin receptor-like kinases: a diverse family playing an important role in cancer.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

Review 7.  Vascular heterogeneity and specialization in development and disease.

Authors:  Michael Potente; Taija Mäkinen
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-24       Impact factor: 94.444

Review 8.  Development of the mammalian lymphatic vasculature.

Authors:  Ying Yang; Guillermo Oliver
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

9.  Type III transforming growth factor beta receptor regulates vascular and osteoblast development during palatogenesis.

Authors:  Cynthia R Hill; Britni H Jacobs; Christopher B Brown; Joey V Barnett; Steven L Goudy
Journal:  Dev Dyn       Date:  2014-12-01       Impact factor: 3.780

10.  Endothelial cell survival during angiogenesis requires the pro-survival protein MCL1.

Authors:  E C Watson; L Whitehead; R H Adams; G Dewson; L Coultas
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.